Literature DB >> 9559036

Major depression in medically ill patients.

B Sutor1, T A Rummans, S G Jowsey, L E Krahn, M J Martin, M K O'Connor, K L Philbrick, J W Richardson.   

Abstract

Major depression is one of the most common psychiatric problems complicating the treatment and prognosis of patients with active medical illness. Recognizing and treating major depressive conditions in this population can often be challenging, even for the most seasoned clinicians. This article reviews the medical and neurologic conditions that have been associated with the high prevalence rates of major depression. Highlights of the evaluation process that help confirm this suspected diagnosis are addressed, and management issues are discussed. Brief reviews of supportive psychotherapeutic tools that the clinician may find helpful are included, as well as current advances in pharmacologic interventions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559036

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

Review 1.  Challenges in treating patients with major depressive disorder: the impact of biological and social factors.

Authors:  Soichiro Sato; Tzung Lieh Yeh
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

2.  Major depression in primary care.

Authors:  A M Rouchell
Journal:  Ochsner J       Date:  2000-04

Review 3.  Prevalence of depression in survivors of acute myocardial infarction.

Authors:  Brett D Thombs; Eric B Bass; Daniel E Ford; Kerry J Stewart; Konstantinos K Tsilidis; Udita Patel; James A Fauerbach; David E Bush; Roy C Ziegelstein
Journal:  J Gen Intern Med       Date:  2006-01       Impact factor: 5.128

4.  Gender, depression and physical impairment: an epidemiologic perspective from Aleppo, Syria.

Authors:  Nael Kilzieh; Samer Rastam; Kenneth D Ward; Wasim Maziak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-02       Impact factor: 4.328

5.  Comorbidity of depression with chronic diseases: a population-based study in Aleppo, Syria.

Authors:  Nael Kilzieh; Samar Rastam; Wasim Maziak; Kenneth D Ward
Journal:  Int J Psychiatry Med       Date:  2008       Impact factor: 1.210

6.  Mechanisms of Psychiatric Comorbidities in Epilepsy.

Authors:  Jamie Maguire
Journal:  Curr Top Behav Neurosci       Date:  2022

7.  Olfactory Dysfunction Predicts the Development of Depression in Older US Adults.

Authors:  Yazan Eliyan; Kristen E Wroblewski; Martha K McClintock; Jayant M Pinto
Journal:  Chem Senses       Date:  2021-01-01       Impact factor: 3.160

8.  Duloxetine in the treatment of major depressive disorder.

Authors:  David J Goldstein
Journal:  Neuropsychiatr Dis Treat       Date:  2007-04       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.